Pretty sure the trial is happening under Dr Jay's
Post# of 148146
[[ I'd speculate that the Alzheimer's partnership is with Dr. Paul Edison of Imperial College London, our former Scientific advisor and whose "work now focuses on neuroinflammation, and the interplay between inflammation and immunity in neurodegenerative and neuroinflammatory disease and relating these with genetic information. He is also evaluating the methods of modulating inflammation and amyloid in Alzheimer’s disease, and the influence of cardiometabolic factors on the development of neurodegenerative diseases by means of clinical and pre-clinical studies." ]]